PhD defence by Ida Vang Andersen
Development of a selective peptide with affinity for alpha-synuclein - Towards a better understanding of the pathogenesis, diagnosis, and treatment of Parkinson's disease
Assessment committee
(Chairperson) Associate professor Vito Foderà, University of Copenhagen
Associate professor Oxana Klementieva, Lund University, Sweden
Dr Raffaella Rossin, Tagworks Pharmaceuticals, University Medical Center, Nijmegen, Netherlands
Supervisors
Associate Professor Matthias Manfred Herth, University of Copenhagen
Associate Professor Annette Eva Langkilde, University of Copenhagen
Professor Kristian Strømgaard, University of Copenhagen
Department
Department of Drug Design and Pharmacology
Graduate programme
Pharmaceutical Sciences
Place of study
The experimental work took place at Department of Drug Design and Pharmacology (Denmark), Department of Clinical Physiology, Nuclear Medicine and PET (Rigshospitalet, Denmark), Neurobiology Research Unit (NRU, Rigshospitalet, Denmark), National Biologics Facility at Danish Technical University (DTU, Denmark), Department of Biomedical Sciences, Core Facility for Integrated Microscopy (CFIM, Panum Denmark), Centre for Structural Systems Biology (CSSB, DESY Germany), European Molecular Biology Laboratory (EMBL, Germany) and Department of Preclinical Imaging and Radiopharmacy (University of Tübingen, Germany).
Place of PhD defence
Auditorium 3
Building 12
PharmaSchool
Universitetsparken 2
2100 Copenhagen
Ask for a copy of the thesis
ida.andersen@sund.ku.dk